Clovis Oncology pays $20 million to settle charges of misleading investors - STAT

Clovis Oncology pays $20 million to settle charges of misleading investors - STAT

STAT Plus: Clovis Oncology pays $20 million to settle charges of misleading investors

By ED SILVERMAN

ALEX HOGAN/STAT

Clovis and its chief executive Patrick Mahaffy made various misleading statements about the effectiveness of a lung cancer drug that was in development.

READ MORE